Yi Ning
Johns Hopkins University
H-index: 37
North America-United States
Top articles of Yi Ning
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cytogenetics and FISH in Precision Molecular Pathology of Aggressive B-Cell Lymphomas | Yi Ning Jocelyn Reader | 2024/2/15 | |
Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms | Leah G Benton Michael Edward Kallen Jonathan L Jacobs Isaac E McCool Yi Ning | 2024/1/1 | |
Cytogenetics and molecular genetics of myelodysplastic neoplasms | Yi Ning Yanming Zhang Michael A Kallen Ashkan Emadi Maria R Baer | 2023/8/16 | |
Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia | Genes | Mary Gudipati Melody Butler Rima Koka Maria R Baer Yi Ning | 2023/2/3 |
Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and IDH1 R132C … | Leukemia & lymphoma | Hanan Alkhaldi Danielle Sewell Yi Ning Michael E Kallen Ashkan Emadi | 2022/10/15 |
Interpretation challenge of small copy number variations in the imprinting regions | Molecular Genetics & Genomic Medicine | Yi Ning Megan Czekalski Sylvia Herrada Carol Greene | 2022/7 |
P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)-SAFETY, EFFICACY AND PK/PD IN THE … | HemaSphere | Yuchen Liu Osman M Bah Dominique Bollino Katherine Caprinolo Jinoos Zarrabi | 2022/6/1 |
When Flow Is Turbulent: CD19 Intensity Is a Pitfall in Acute Leukemia Classification | AJSP: Reviews & Reports | Michael E Kallen Ashkan Emadi Vu H Duong Maria R Baer Yi Ning | 2022/5/1 |
Attack of the clones: a T-cell population resembling adult T-cell leukemia/lymphoma, and large granular lymphocytosis, in an HTLV-2-infected patient | Journal of Hematopathology | Michael E Kallen Yoshine Saito Nancy M Hardy Yi Ning Timothy Singleton | 2022/12 |
Therapy-related B-lymphoblastic leukemia after multiple myeloma | Leukemia research reports | Michael E Kallen Rima Koka Zeba N Singh Yi Ning Mehmet H Kocoglu | 2022/1/1 |
Phase 1 dose escalation trial of pegcrisantaspase in combination with Venetoclax in adults with relapsed or refractory Acute Myeloid Leukemia | Blood | Dominique R Bollino Yuchen Liu Osman Mohamed Bah Katherine Caprinolo Jinoos Zarrabi | 2022/11/15 |
Significance of distinguishing 3'-IGH deletion from 5'-IGH deletion in multiple myeloma. | Genes, Chromosomes & Cancer | Yi Ning | 2020/10/1 |
